Cannabis and Emerging Medicines Services

FTI Consulting offers a broad range of solutions for the cannabis and emerging medicines industries to enhance reputation, maintain brand integrity, and ensure regulatory compliance, all while bolstering profitability. We understand the unique challenges and opportunities presented to these industries in the United States, Canada, and across the globe.

At every phase of the business lifecycle, from entrepreneurial startup to multi-national corporation, FTI Consulting offers the cannabis and emerging medicines industries a suite of solutions and services that address specific business challenges around regulatory compliance, financial and operational discipline, business disputes, mergers and acquisitions, brand integrity and reputational enhancement. Our team understands the unique challenges of the industries from local, national and global perspectives as one of the first major U.S.-based business advisory firms to establish a cannabis-specific practice. FTI Consulting is committed to helping the industry grow and succeed.

Where We Can Help

Our team offers a full suite of multidisciplinary solutions to the cannabis and emerging medicines industries from litigation and dispute services including expert witness testimony, financial transaction services including restructuring, transaction advisory, and carve-out solutions, regulatory services including forensic accounting and investigations, anti-money laundering, and reputational due diligence, and risk solutions including public relations.

Disclaimer: Possessing, using, distributing, and/or selling marijuana or marijuana-based products is illegal under federal law, regardless of any state law that may decriminalize such activity under certain circumstances. Although federal enforcement policy may at times defer to states’ laws and not enforce conflicting federal laws, interested businesses and individuals should be aware that compliance with state law in no way assures compliance with federal law, and there is a risk that conflicting federal laws may be enforced in the future. No advice we give is intended to provide any guidance or assistance in violating federal law.

Services for the Cannabis and Emerging Medicines Industries

The challenges facing cannabis and emerging medicines companies require solutions to address regulatory compliance, financial and operational discipline, brand integrity, and reputational enhancement.

Download Brochure